VAERS reports by lot

Pfizer COVID-19 lot EWO151: VAERS reports

38 VAERS reports list lot EWO151 as a Pfizer COVID-19 vaccine, received between 2021-04-06 and 2023-08-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
13%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3426%
Neurological2318%
Musculoskeletal2116%
Gastrointestinal1612%
Dermatological (non-injection-site)97%
Cardiac / Cardiovascular75%
Respiratory75%
Allergic / Anaphylactic43%
Injection-site / Local reaction43%
Psychiatric / Neuropsychiatric22%
Reproductive / Menstrual22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Pennsylvania4
New Jersey4
Colorado2
Arizona2
New York2
Florida2
Tennessee2
Washington1
Georgia1
Oregon1
Michigan1

Reports by month received

2021-047
2021-057
2021-061
2021-073
2021-086
2021-095
2021-103
2021-112
2022-011
2022-041
2022-091
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.